Randomized trial of mycophenolate mofetil versus enteric-coated mycophenolate sodium in primary renal transplantation with tacrolimus and steroid avoidance: Four-year analysis

Transplantation

Volumn 91, Issue 11, 2011, Pages 1198-1205

  Ciancio, Gaetano ^a   Gaynor, Jeffrey J ^a   Zarak, Alberto ^a   Sageshima, Junichiro ^a   Guerra, Giselle ^a   Roth, David ^a   Brown, Randolph ^a   Kupin, Warren ^a   Chen, Linda ^a   Tueros, Lissett ^a   Hanson, Lois ^a   Ruiz, Phillip ^a   Burke, George W ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Biopsy proven acute rejection; Enteric coated mycophenolate sodium; Graft survival; Mycophenolate mofetil; Renal transplant recipients; Steroid avoidance; Tacrolimus

Indexed keywords

CREATININE; DACLIZUMAB; METHYLPREDNISOLONE; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS; THYMOCYTE ANTIBODY;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; BACTEREMIA; CELLULITIS; CLOSTRIDIUM DIFFICILE INFECTION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CYTOMEGALOVIRUS INFECTION; DEATH; DIABETES MELLITUS; DIARRHEA; DIVERTICULITIS; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; ENDOCARDITIS; EPIDIDYMITIS; EPIGASTRIC PAIN; FEMALE; FISTULA; FOLLOW UP; FOOT DISEASE; FOOT INFECTION; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL SYMPTOM; GIARDIASIS; GLOMERULUS FILTRATION RATE; GRAFT FAILURE; GRAFT SURVIVAL; HERPES ZOSTER; HOSPITALIZATION; HUMAN; HUMAN TISSUE; INFECTION; KAPOSI SARCOMA; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; NAUSEA; PNEUMONIA; PRIORITY JOURNAL; PROSTATITIS; PYELONEPHRITIS; RANDOMIZED CONTROLLED TRIAL; THROMBOPHLEBITIS; TREATMENT RESPONSE; UPPER RESPIRATORY TRACT INFECTION; URINARY TRACT INFECTION; VOMITING; WOUND INFECTION;

ADOLESCENT; ADRENAL CORTEX HORMONES; ADULT; AGED; FEMALE; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MYCOPHENOLIC ACID; TABLETS, ENTERIC-COATED; TACROLIMUS;

EID: 79958295104     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3182003d76     Document Type: Article

References (26)

1. Ekberg H, Tedesco-Silva H, Demirbas A, et al. Reduced exposure to calcineurin inhibitors in renal transplantation. N Engl J Med 2007; 357: 2562.
2. Matas AJ, Kandaswamy R, Gillingham KJ, et al. Prednisone-free maintenance immunosuppression-A 5-year experience. Am J Transplant 2005; 5: 2473.
3. Vincenti F, Larsen C, Durrbach A, et al; the belatacept study group. Costimulation blockade with belatacept in renal transplantation. N Engl J Med 2005; 353: 770.
4. Ekberg H, Bernasconi C, Tedesco-Silva H, et al. Calcineurin inhibitor minimization in the symphony study: Observational results 3 years after transplantation. Am J Transplant 2009; 9: 1876.
5. Ciancio G, Burke GW, Gaynor JJ, et al. Randomized trial of mycophenolate mofetil versus enteric-coated mycophenolate sodium in primary renal transplant recipients given tacrolimus and daclizumab/thymoglobulin: One year follow-up. Transplantation 2008; 86: 67.
6. Salvadori M, Holzer H, de Mattos A, et al. Enteric-coated mycophenolate sodium is therapeutically equivalent to mycophenolate mofetil in de novo renal transplant patients. Am J Transplant 2003; 4: 231.
7. Budde K, Curtis J, Knoll G, et al. Enteric-coated mycophenolate sodium can be safely administered in maintenance renal transplant patients: Results of a 1-year study. Am J Transplant 2003; 4: 237.
8. Burke GW, Ciancio G, Figueiro J, et al. Can acute rejection be prevented in SPK transplantation? Transplant Proc 2002; 34: 1913.
9. BurkeGWIII, Ciancio G, Figueiro J, et al. Steroid-resistant acute rejection following SPK: Importance of maintaining therapeutic dosing in a triple-drug regimen. Transplant Proc 2002; 34: 1918.
10. Sageshima J, Ciancio G, Gaynor JJ, et al. Addition of anti-CD25 to thymoglobulin for induction therapy: Delayed return of peripheral blood CD25 positive population. Clin Transplant (in press).
11. Ruggenenti P, Codreanu I, Cravedi P, et al. Basiliximab combined with low-dose rabbit anti-human thymocyte globulin: A possible further step toward effective and minimally toxic T cell-targeted therapy in kidney transplantation. Clin J Am Soc Nephrol 2006; 1: 546.
12. Kandus A, Arnol M, Omahen K, et al. Basiliximab versus daclizumab combined with triple immunosuppression in deceased donor renal transplantation: A prospective, randomized study. Transplantation 2010; 89: 1022.
13. Ciancio G, Gaynor JJ, Sageshima J, et al. Favorable outcomes with machine perfusion and longer pump times in kidney transplantation: A single center, observational study. Transplantation 2010;90: 882-890.
14. Ojo AO, Meier-Kriesche HU, Hanson JA, et al. Mycophenolate mofetil reduces late renal allograft loss independent of acute rejection. Transplantation 2000; 69: 2405.
15. Gregory CR, Huang X, Pratt RE, et al. Treatment with rapamycin and mycophenolic acid reduces arterial intimal thickening produced by mechanical injury and allows endothelial replacement. Transplantation 1995; 59: 655.
16. Humar A, Hassoun A, Kandaswamy R, et al. Immunologic factors: The major risk for decreased long-term renal allograft survival. Transplantation 1999; 68: 1842.
17. Woodle ES, First MR, Pirsch J, et al.Aprospective randomized, doubleblind, placebo-controlled multicenter trial comparing early (7 day) corticosteroid cessation versus long-term, low-dose corticosteroid therapy. Ann Surg 2008; 248: 564.
18. Knight SR, Morris PJ. Steroid avoidance or withdrawal after renal transplantation increases the risk of acute rejection but decreases cardiovascular risk. A meta-analysis. Transplantation 2010; 89: 1.
19. Parrott NR, Hammad AQ, Watson CJ, et al. Multicenter, randomized study of the effectiveness of basiliximab in avoiding addition of steroids to cyclosporine A monotherapy in renal transplant recipients. Transplantation 2005; 79: 344-348. (Pubitemid 40299542)
20. Vincenti F, Monaco A, Grinyo J, et al. Multicenter randomized prospective trial of steroid withdrawal in renal transplant recipients receiving basiliximab, cyclosporine microemulsion and mycophenolate mofetil. Am J Transplant 2003; 3: 306.
21. Woodle ES, Vincenti F, Lorber MI, et al. A multicenter pilot study of early (4-day) steroid cessation in renal transplant recipients under simulect, tacrolimus and sirolimus. Am J Transplant 2005; 5: 157.
22. Ciancio G, Burke GW, Gaynor JJ, et al. A randomized long-term trial of tacrolimus/sirolimus versus tacrolimus/mycophenolate versus cyclosporine/ sirolimus in renal transplantation: Three-year analysis. Transplantation 2006; 81: 845.
23. Ciancio G, BurkeGW,Gaynor JJ, et al.Arandomized trial of three renal transplant induction antibodies: Early comparison of tacrolimus, mycophenolate mofetil, and steroid dosing, and newer immune-monitoring. Transplantation 2005; 80: 457.
24. Levey AS, Bosch JP, Lewis JB, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130: 461.
25. Solez K, Colvin RB, Racusen LC, et al. Banff 07 classification of renal allograft pathology: Updates and future directions. Am J Transplant 2008; 8: 753.
26. Snedecor GW, Cochran WG. Statistical methods [ed. 6]. Ames, Iowa: The Iowa State University Press, 1967.